Prophylactic Therapy With TB Drug Effective In HIV Patients, Study Shows

Bloomberg News: Combining Tuberculosis Treatment With HIV Therapy Cuts Disease
“The use of tuberculosis drug isoniazid in conjunction with antiretroviral therapy to prevent the disease among HIV-infected patients is safe and cuts the incidence of TB by 37 percent, according to a study…” (Kew, 6/6).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.